Improving Prices Spur Hope of Recovery for Generic Drug Stocks

(Bloomberg) -- Generic drugmakers are finally starting to see the light at the end of the tunnel as copy-cat drug prices rise for the first time in two years, according to SVB Leerink.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.